A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group
- 1 July 2010
- journal article
- review article
- Published by Elsevier BV in Value in Health
- Vol. 13 (5), 657-666
- https://doi.org/10.1111/j.1524-4733.2010.00725.x
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Assessing A Structured, Quantitative Health Outcomes Approach To Drug Risk-Benefit AnalysisHealth Affairs, 2007
- How the US Drug Safety System Should Be ChangedJAMA, 2006
- Reform of Drug Regulation — Beyond an Independent Drug-Safety BoardThe New England Journal of Medicine, 2006
- Safety in Numbers — Monitoring Risk in Approved DrugsThe New England Journal of Medicine, 2005
- A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertaintyJournal of Clinical Epidemiology, 2005
- The Precautionary Principle and Pharmaceutical Risk ManagementDrug Safety, 2005
- Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosisJournal of Clinical Epidemiology, 2004
- Practical pharmacovigilance analysis strategiesPharmacoepidemiology and Drug Safety, 2002
- Coverage by the News Media of the Benefits and Risks of MedicationsThe New England Journal of Medicine, 2000
- Benefit/Risk Assessment: What Patients Can Know That Scientists CannotDrug Information Journal, 1993